Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC5A1 |
| Upstream (Parents) |
|---|
| (<<) B3GNT3 → SLC5A1 |
| (<<) BBS1 → SLC5A1 |
| (<<) BCAR1 → SLC5A1 |
| (<<) BCL3 → SLC5A1 |
| (<<) CACNA1I → SLC5A1 |
| (<<) CDC42EP2 → SLC5A1 |
| (<<) CEACAM1 → SLC5A1 |
| (<<) EREG → SLC5A1 |
| (<<) GAS5 → SLC5A1 |
| (<<) GNE → SLC5A1 |
| (<<) GRK5 → SLC5A1 |
| (<<) ITGA2 → SLC5A1 |
| (<<) KCNJ2 → SLC5A1 |
| (<<) KCNN4 → SLC5A1 |
| (<<) LOC441245 → SLC5A1 |
| (<<) MAFF → SLC5A1 |
| (<<) MRAS → SLC5A1 |
| (<<) NCOA7 → SLC5A1 |
| (<<) NFIA → SLC5A1 |
| (<<) PHLDA1 → SLC5A1 |
| (<<) PLEK2 → SLC5A1 |
| (<<) RNASE7 → SLC5A1 |
| (<<) SDCBP2 → SLC5A1 |
| (<<) SLPI → SLC5A1 |
| (<<) STEAP1 → SLC5A1 |
| (<<) THEM5 → SLC5A1 |
| (<<) THRA → SLC5A1 |
| (<<) TNFRSF11A → SLC5A1 |
| (<<) TSPAN3 → SLC5A1 |
| (<<) ZNF461 → SLC5A1 |
| Downstream (Children) |
|---|
| SLC5A1 → ARSJ (>>) |
| SLC5A1 → BBC3 (>>) |
| SLC5A1 → EGF (>>) |
| SLC5A1 → FAM46B (>>) |
| SLC5A1 → FUT2 (>>) |
